Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 21 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

GSBS Therapeutics & Pharmacology Program, 12 Jul 2019

Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs) like erlotinib are effective for treating patients…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.